Industry Practices Inditherm |
5 year maintenance and extended warranty was £129,000. The project plan therefore represented an estimated saving of over £61,000 using very conservative assumptions, with the annual savings rising to a level of over £57,000 per year.
Clinical Implementation It was decided that the Trust would equip 31 of the 43 operating theatres and 11 recovery beds to match the case loads and needs of the different hospitals. A mix of different mattress sizes was purchased to allow for different procedure types and operating tables. During the period after full
Changing from forced air patient warming to Inditherm Alpha saved money and time for Pennine Acute NHS Trust
The future of patient warming
T
he Pennine Acute NHS Trust had used forced air patient warming in their operating theatres and
recovery rooms for many years. All four hospitals in the Trust have now changed to using Inditherm Alpha patient warming mattresses and blankets after carrying out a clinical evaluation and gaining approval for a business case based on outright purchase of the Inditherm system. The initial driving factor for change
was to improve clinical care by making it more practical to warm all patients effectively. It was identified during the evaluation process that the change could also deliver significant cost savings and this strengthened the business case. The NICE guidance relating to the Inditherm system (MTG7) provided strong evidence that gave the Trust confidence in its own evaluation and expectations. A review carried out 8 months
after implementation of the change of warming technology has shown that the Trust has already exceeded the cost savings planned for the first two
years, amounting to over £56,000. Pennine Acute Trust comprises four
separate hospitals and is the largest non-teaching hospital trust in the UK. The Trust had been spending just over £107,000 per year on forced air warming disposable blankets, following the issue of NICE Clinical Guidance on perioperative hypothermia, issued in 2008, before implementation of the Inditherm system. With a total of around 23,600 surgical cases per year this represented warming of approximately 50% of patients having general or regional anaesthesia. A product evaluation was undertaken
with three selected products, all reusable patient warming technologies. Each product was trialled for a period of 4 weeks in the main operating theatre suite at the Royal Oldham Hospital and was audited for clinical performance, particularly patient temperature outcomes, along with feedback from the staff on suitability of the device for use with the procedures carried out at the hospital. The Inditherm Alpha system was selected as the product of choice as it met the clinical criteria in maintaining patient temperature and was well received by the staff in the department. The cost of purchase, along with
60 Global Opportunity Healthcare 2015 | Issue 01
implementation of the Inditherm system ongoing costs of air warming have been monitored and compared on a monthly basis to the same period in the previous year. Eight months after introduction of the Inditherm systems these cost savings were analysed as follows: There is a clear pattern of sustained
savings from month to month, and good confidence that the forward projections will be achieved if not exceeded. From a clinical perspective there
is a significant advantage as all patients in the theatres equipped with Inditherm systems can be warmed at no incremental cost. The percentage of patients warmed is now very much higher than was the case when using forced air warming, helping to ensure compliance with the recommendations of NICE for the prevention of unplanned perioperative hypothermia (CG65). It is clear from results actually delivered
in practice in a complex, multi-site group of hospitals that substantial cost savings can be made. In this Trust the business case has been significantly exceeded and a payback on capital expenditure will be returned in the first year, with some savings achieved. The five year financial return will run to nearly £300,000 for an installation with warming for 31 operating theatres and 11 recovery beds.
References Inditherm patient warming mattress for the prevention of inadvertent hypothermia. NICE medical technology guidance 7. Issued August 2011.
www.nice.org.uk/mtg7 Inadvertent perioperative hypothermia. The manage- ment of inadvertent perioperative hypothermia in adults. NICE clinical guideline 65. Issued April 2008
Further information
www.inditherm.co.uk
global-opportunity.co.uk
|
Inditherm
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128